AR and cancer: We found that although the AR negative cell line DU145 disclosed heterogeneity in AR methylation signature, AR re-expression was not successfully accomplished upon 5-aza-2-deoxycytidine (DAC) and Trichostatin A (TSA) exposure, due to the increase in repressive histone markers acting as alternative protective mechanism fostering cancer cell survival [11].